1. Home
  2. CLRO vs BCDA Comparison

CLRO vs BCDA Comparison

Compare CLRO & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRO
  • BCDA
  • Stock Information
  • Founded
  • CLRO 1983
  • BCDA N/A
  • Country
  • CLRO United States
  • BCDA United States
  • Employees
  • CLRO N/A
  • BCDA N/A
  • Industry
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLRO Technology
  • BCDA Health Care
  • Exchange
  • CLRO Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • CLRO 12.5M
  • BCDA 10.1M
  • IPO Year
  • CLRO N/A
  • BCDA N/A
  • Fundamental
  • Price
  • CLRO $0.34
  • BCDA $2.16
  • Analyst Decision
  • CLRO
  • BCDA Strong Buy
  • Analyst Count
  • CLRO 0
  • BCDA 1
  • Target Price
  • CLRO N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • CLRO 163.7K
  • BCDA 78.3K
  • Earning Date
  • CLRO 05-19-2025
  • BCDA 05-14-2025
  • Dividend Yield
  • CLRO 142.86%
  • BCDA N/A
  • EPS Growth
  • CLRO N/A
  • BCDA N/A
  • EPS
  • CLRO N/A
  • BCDA N/A
  • Revenue
  • CLRO $10,077,000.00
  • BCDA $3,000.00
  • Revenue This Year
  • CLRO N/A
  • BCDA N/A
  • Revenue Next Year
  • CLRO N/A
  • BCDA N/A
  • P/E Ratio
  • CLRO N/A
  • BCDA N/A
  • Revenue Growth
  • CLRO N/A
  • BCDA N/A
  • 52 Week Low
  • CLRO $0.34
  • BCDA $1.63
  • 52 Week High
  • CLRO $1.40
  • BCDA $5.69
  • Technical
  • Relative Strength Index (RSI)
  • CLRO 31.34
  • BCDA 46.19
  • Support Level
  • CLRO $0.35
  • BCDA $1.80
  • Resistance Level
  • CLRO $0.55
  • BCDA $2.92
  • Average True Range (ATR)
  • CLRO 0.05
  • BCDA 0.23
  • MACD
  • CLRO -0.02
  • BCDA -0.04
  • Stochastic Oscillator
  • CLRO 8.27
  • BCDA 32.14

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: